Houston-based CS Disco announced on Thursday that it has closed on a $10 million Series B round of funding.
The company makes software that enables attorneys to better find and organize the millions of documents gathered for cases during the discovery... Read more »
Amazon isn’t providing a lot of details—surprise, surprise—on its commitment to power its data centers with 100 percent renewable energy.
Meanwhile, Northwest startups working on energy storage and water management won the Seattle Angel Conference and the Washington Technology Industry Association’s... Read more »
For more than a decade researchers have been unleashing a deluge of information about the role of genes in disease, based on automated sequencing of DNA. Genetic tests on individual patients are slowly becoming more common, more detailed, and less costly.... Read more »
Trying to run an electric car from solar cells on the car’s roof makes no sense—or so I thought. Earlier this week, I met with Daniel Theobald, the CTO of healthcare company Vecna, who has been driving a solar-powered Volkswagen bus... Read more »
When we started recruiting speakers for Xconomy’s Tech Agenda 2015, we had a few major goals: Assemble a group of top-notch leaders that represents a healthy cross-section of innovation happening today. Make sure they’re all women. Make the program about... Read more »
San Diego-based BioNano Genomics, which has taken a fundamentally different approach to analyzing the genome, says today it has closed on $53 million in Series C financing to expand its commercialization efforts in North America, China, and Europe.
Legend Capital, a... Read more »
We’re one month away from our annual biotech event in San Francisco. This year, it’s called Xconomy Forum: Innovation at Biotech’s Epicenter, and we’re gathering December 17 in the Mission Bay neighborhood to talk about the emerging science, great ideas,... Read more »
Snow? What snow? The only thing piling up at astonishing rates on the West Coast this week is biotech news. Up in Seattle, the Fred Hutchinson Cancer Research Center has unveiled its new president, and its neighbor Juno Therapeutics filed to... Read more »
N30 Pharmaceuticals, a Boulder-based pharmaceutical company developing drugs for cystic fibrosis, announced yesterday it has raised a $30 million mezzanine financing round. N30 Pharma will use the funds to continue clinical trials for N91115, for which it recently completed a... Read more »